- Matinas BioPharma ( NYSE: MTNB ) appoints current board member, Eric J. Ende, to succeed Herbert J. Conrad as Chairman of the Board, effective October 1, 2022.
- Mr. Conrad is the founding Chairman of the company will remain on the Board as an independent director of the company.
- Dr. Ende joined the Company’s Board of Directors in March 2017 and is currently on the Board of Directors of Avadel plc, where he is the Chairman of the Nomination & Corporate Governance Committee and is serving on the Audit Committee and is also on the Technology Transfer Committee of Mount Sinai Innovation Partners.
For further details see:
Eric J. Ende is the new Chairman of the Board of Matinas Biopharma